Search hospitals > Iowa > Des Moines
Mercy Medical Center - Des Moines
Claim this profileDes Moines, Iowa 50314
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Ovarian Cancer
Conducts research for Breast cancer
388 reported clinical trials
6 medical researchers
Summary
Mercy Medical Center - Des Moines is a medical facility located in Des Moines, Iowa. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Ovarian Cancer, Breast cancer and other specialties. Mercy Medical Center - Des Moines is involved with conducting 388 clinical trials across 512 conditions. There are 6 research doctors associated with this hospital, such as Richard L. Deming, Mehmet S. Copur, Atul Chawla, MD, and Robert Hoyt, MD.Area of expertise
1Breast Cancer
Global LeaderER positive
Stage IV
HER2 negative
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Richard L. DemingMercy Medical Center - Des Moines6 years of reported clinical research
Expert in Breast Cancer
Expert in Cancer
178 reported clinical trials
242 drugs studied
Mehmet S. CopurBethesda North Hospital13 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
3 reported clinical trials
14 drugs studied
Atul Chawla, MDMercy Hospital Medical Center8 years of reported clinical research
Studies Stroke
Studies Heart Disease
3 reported clinical trials
3 drugs studied
Robert Hoyt, MDIowa Heart Center7 years of reported clinical research
Studies Atrial Fibrillation
Studies Bleeding
3 reported clinical trials
4 drugs studied
Clinical Trials running at Mercy Medical Center - Des Moines
Lung Cancer
Breast Cancer
Bladder Cancer
Cancer
Breast cancer
Pancreatic Cancer
Colorectal Cancer
Multiple Myeloma
Prostate Cancer
Ovarian Cancer
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Mercy Medical Center - Des Moines?
Mercy Medical Center - Des Moines is a medical facility located in Des Moines, Iowa. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Ovarian Cancer, Breast cancer and other specialties. Mercy Medical Center - Des Moines is involved with conducting 388 clinical trials across 512 conditions. There are 6 research doctors associated with this hospital, such as Richard L. Deming, Mehmet S. Copur, Atul Chawla, MD, and Robert Hoyt, MD.
Where is Mercy Medical Center - Des Moines located?
MercyOne Des Moines Medical Center is located at 1111 6th Ave, Des Moines, IA 50314.
Who should I call to ask about financial aid or insurance network?
**Financial Assistance and Insurance Information for Mercy Medical Center - Des Moines**
- **Mercy Health Financial Assistance Policy**: Offers financial aid to eligible patients based on income and financial resources. Information and applications are available on their website.
- **MercyOne Financial Assistance Program**: Provides financial assistance for medical bills to eligible uninsured or underinsured patients. Application and policy details are on their website.
- **MercyOne Billing & Finances**: For billing and financial inquiries, contact MercyOne at the following numbers: Clinic - 888-515-7155, Hospital - 734-343-3065, Iowa Heart - 515-633-3600, Lab - 844-405-9080. Financial counselors are available to discuss individual needs and payment arrangements.
- **MercyOne Insurance**: At registration, provide your insurance information. MercyOne will file your claim and, if possible, inform you of the approximate amount owed and arrange for payment.
- **MercyOne Discounted Charges**: Hospital patients without insurance who meet income guidelines may receive a discount off total billed charges. An application is required.
What insurance does Mercy Medical Center - Des Moines accept?
Mercy Medical Center - Des Moines accepts a broad spectrum of insurance plans, including Medicare, Medicaid, and commercial carriers like Aetna, Humana, United Healthcare, and Wellmark (BCBS). Patients are encouraged to confirm coverage and any restrictions with their insurance provider prior to scheduling visits. Note that non-participating insurance plans may lead to the patient being responsible for total billed charges.
What awards or recognition has Mercy Medical Center - Des Moines received?
Mercy Medical Center - Des Moines is an accredited cancer center by the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), highlighting its quality cancer care. It has been named a Best Regional Hospital for Des Moines and central Iowa by U.S. News & World Report. Additionally, it has earned the Blue Distinction Center Plus (+) designation for cardiac care from Blue Cross Blue Shield.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.